SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (1005)6/16/1997 11:39:00 PM
From: Richard Belanger   of 1762
 
Pseudo/Max - The the issue of Bexxar patient hospitalization was discussed on this thread some time ago (see Post 372 for starters). In essence, the treating hospital can release the patient if they perform an analysis and give the patient proper instruction in accordance with a recently issued Nuclear Regulatory Commission Guide. According to Roger, statements made at annual meeting seem to indicate that Idec still believes that hospitalization will be the rule, rather than the exception. But there is no question that, in most States, the hospital will have the option of releasing the patient if they so choose.

Rich
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News